InsidersTradesSigma
Discover the full insider trade history of Telomir Pharmaceuticals, Inc., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €85.3m. The latest transaction was filed on 15 February 2024 (Acquisition). Among the most active insiders: Bay Shore Trust. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
1 of 1 declaration